Haitao F. Tao

28 Fuxing Road
Beijing, 100853, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Single-cell profiling reveals FAM117A as a key regulator linking macrophage-epithelial crosstalk with the progression of lung adenocarcinoma.

Single-cell profiling reveals FAM117A as a key regulator linking macrophage-epithelial crosstalk with the progression of lung adenocarcinoma.

Journal: Experimental hematology & oncology

Published: December 09, 2025

Safety and efficacy of Cisplatin in combination with Sintilimab and Niraparib in patients with advanced solid tumors: A phase Ib study.

Safety and efficacy of Cisplatin in combination with Sintilimab and Niraparib in patients with advanced solid tumors: A phase Ib study.

Journal: Cancer pathogenesis and therapy

Published: May 08, 2025

Immune Checkpoint Inhibitor Without Pemetrexed for First-line Maintenance Therapy in Advanced Lung Adenocarcinoma: A Real-World Retrospective Study.

Immune Checkpoint Inhibitor Without Pemetrexed for First-line Maintenance Therapy in Advanced Lung Adenocarcinoma: A Real-World Retrospective Study.

Journal: Clinical lung cancer

Published: May 08, 2025

Comparative outcomes of first-line PD-1/PD-L1 inhibitors plus chemotherapy for advanced squamous non-small cell lung cancer: a systematic review and network meta-analysis of randomized clinical trials.

Comparative outcomes of first-line PD-1/PD-L1 inhibitors plus chemotherapy for advanced squamous non-small cell lung cancer: a systematic review and network meta-analysis of randomized clinical trials.

Journal: Translational lung cancer research

Published: January 22, 2025

TP63 mediates the generation of tumour-specific chromatin loops that underlie MYC activation in radiation-induced tumorigenesis.

TP63 mediates the generation of tumour-specific chromatin loops that underlie MYC activation in radiation-induced tumorigenesis.

Journal: Nature communications

Published: December 18, 2024

Integrating genomic and pathological characteristics to enhance prognostic precision in advanced NSCLC.

Integrating genomic and pathological characteristics to enhance prognostic precision in advanced NSCLC.

Journal: NPJ precision oncology

Published: August 27, 2024

Efficacy and safety of camrelizumab plus famitinib in patients with previously treated non-small-cell lung cancer: a single-arm, phase II trial.

Efficacy and safety of camrelizumab plus famitinib in patients with previously treated non-small-cell lung cancer: a single-arm, phase II trial.

Journal: Therapeutic advances in medical oncology

Published: August 27, 2024

Treatment strategies with combined agency against severe viral pneumonia in patients with advanced cancer.

Treatment strategies with combined agency against severe viral pneumonia in patients with advanced cancer.

Journal: Journal of translational internal medicine

Published: July 31, 2024

RET-AREAL: A multi-center, real-world data analysis on the efficacy of pralsetinib in acquired RET fusion after resistance to EGFR/ALK-TKIs.

RET-AREAL: A multi-center, real-world data analysis on the efficacy of pralsetinib in acquired RET fusion after resistance to EGFR/ALK-TKIs.

Journal: Cancer letters

Published: July 23, 2024

First-line treatment with HDACis plus tislelizumab combined with chemotherapy in advanced NSCLC: a single-arm phase II study.

First-line treatment with HDACis plus tislelizumab combined with chemotherapy in advanced NSCLC: a single-arm phase II study.

Journal: The oncologist

Published: June 14, 2024

Spatial proteomic profiling elucidates immune determinants of neoadjuvant chemo-immunotherapy in esophageal squamous cell carcinoma.

Spatial proteomic profiling elucidates immune determinants of neoadjuvant chemo-immunotherapy in esophageal squamous cell carcinoma.

Journal: Oncogene

Published: May 15, 2024

The application of 3D bioprinting in ophthalmology

The application of 3D bioprinting in ophthalmology

Journal: [Zhonghua yan ke za zhi] Chinese journal of ophthalmology

Published: December 07, 2023

Showing 1-12 of 60

Last Updated: 09/26/2026